RA Chem Pharma Limited is a vertically integrated pharmaceutical company.Over the past 10 years, it has expanded its spectrum
by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research.
RA Chem Pharma Limited is a vertically integrated pharmaceutical company.Over the past 10 years, it has expanded
its spectrum by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research.
cGMP compliant API manufacturing facility located in Jaggayapet, Krishna District
cGMP compliant solid dosage formulation manufacturing facility at Nacharam,
Acquired API facility at Jaggaiahpet
Upgraded the API facility to GMP standards
. API facility was made FDA compliant
. Entered Formulation Business
.Started Clinical Research and Biosciences
.Acquired formulation at Balanagar
USFDA approval for API plant
Obtained MHRA approval for CRBio (Project-based)
.MOH Turkey approval for CRBio
.Japanese approval for API
Expansion of API facility
Expansion of CRBio facility
“Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment."
RA Chem Pharma was built with a focused, long-term philosophy
Unwavering commitment to quality in all aspects – from building state-of-the-art facilities and technology, to employees being trained to maintain highest quality and regulatory standards.
We at RA Chem Pharma Ltdare committed towards a common goal of total customer satisfaction and confidence by providing end to end services to all the clients by continually improving Quality Management System in accordance with cGMP, other regulatory and statutory guidelines.
We shall strive to become globally respected partner driven by strong research & technical capabilities with emphasis on intellectual property and confidentiality.
We as a cohesive & dynamic team shall strive to exceed stakeholders expectations by focusing on customer requirements, empowering employees and maximizing organizational profitability &shareholder wealth.
Commercial Products, Manufactured under Exclusivity, New Products for Commercial Launch
Lamotrigine, Midazolam, Tamsulosin, Fexofenadine, Entacapone, Donepezil,Pranlukast
Commercialized, Scale up, Development Pipeline, SUSPENSIONS
Commericialized, Underdevelpment